NCT01200654View on ClinicalTrials.gov

Population Pharmacokinetics of Linezolid

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Methicillin-Resistant Staphylococcus AureuS
Interventions
DRUG

Linezolid

Dosage of 600 mg discontinuous administration twice a day was about studies in safety volunteers

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT01200654 - Population Pharmacokinetics of Linezolid | Biotech Hunter | Biotech Hunter